Sartorius Stedim Biotech SA (DIM) — Working Capital to Net Assets Ratio
Sartorius Stedim Biotech SA (DIM) has a Working Capital to Net Assets ratio of 4.4% as of June 2026. Working capital of €186.30 Million (current assets of €1.35 Billion minus current liabilities of €1.17 Billion) is measured against net assets of €4.25 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Sartorius Stedim Biotech SA (DIM) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sartorius Stedim Biotech SA Working Capital to Net Assets (2005–2025)
This chart shows how Sartorius Stedim Biotech SA's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of June 2026, the ratio stands at 4.4%, reflecting working capital of €186.30 Million against net assets of €4.25 Billion EUR. For the complete balance sheet picture, see total assets of Sartorius Stedim Biotech SA.
Annual Working Capital to Net Assets for Sartorius Stedim Biotech SA (2005–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sartorius Stedim Biotech SA from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Sartorius Stedim Biotech SA's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.7% | €29.10 Million | €4.13 Billion | €1.44 Billion | €1.41 Billion | ▼ -19.2 pp |
| 2024 | 19.9% | €802.20 Million | €4.02 Billion | €1.74 Billion | €938.80 Million | ▲ +2.1 pp |
| 2023 | 17.9% | €477.80 Million | €2.67 Billion | €1.42 Billion | €937.30 Million | ▼ -7.4 pp |
| 2022 | 25.3% | €635.30 Million | €2.51 Billion | €1.67 Billion | €1.04 Billion | ▲ +1.1 pp |
| 2021 | 24.1% | €418.51 Million | €1.73 Billion | €1.46 Billion | €1.04 Billion | ▲ +3.4 pp |
| 2020 | 20.7% | €307.52 Million | €1.48 Billion | €875.22 Million | €567.69 Million | ▲ +3.2 pp |
| 2019 | 17.5% | €206.46 Million | €1.18 Billion | €633.80 Million | €427.35 Million | ▲ +1.2 pp |
| 2018 | 16.3% | €170.55 Million | €1.04 Billion | €552.53 Million | €381.98 Million | ▲ +0.4 pp |
| 2017 | 16.0% | €140.40 Million | €879.45 Million | €490.85 Million | €350.44 Million | ▼ -3.3 pp |
| 2016 | 19.3% | €147.37 Million | €763.56 Million | €431.73 Million | €284.36 Million | ▲ +7.2 pp |
| 2015 | 12.1% | €78.14 Million | €647.22 Million | €350.83 Million | €272.69 Million | ▲ +3.4 pp |
| 2014 | 8.7% | €46.58 Million | €538.51 Million | €276.17 Million | €229.58 Million | ▼ -13.0 pp |
| 2013 | 21.6% | €104.12 Million | €481.84 Million | €258.51 Million | €154.38 Million | ▲ +22.7 pp |
| 2012 | -1.1% | €-4.62 Million | €434.72 Million | €225.84 Million | €230.46 Million | ▼ -14.2 pp |
| 2011 | 13.1% | €51.95 Million | €395.63 Million | €220.15 Million | €168.20 Million | ▲ +4.5 pp |
| 2010 | 8.6% | €31.46 Million | €365.07 Million | €176.37 Million | €144.91 Million | ▼ -8.1 pp |
| 2009 | 16.8% | €65.88 Million | €393.20 Million | €185.57 Million | €119.69 Million | ▼ -0.8 pp |
| 2008 | 17.5% | €65.10 Million | €371.65 Million | €163.21 Million | €98.11 Million | ▲ +34.2 pp |
| 2007 | -16.7% | €-60.55 Million | €362.76 Million | €161.71 Million | €222.26 Million | ▼ -65.1 pp |
| 2006 | 48.4% | €81.71 Million | €168.93 Million | €202.07 Million | €120.37 Million | ▼ -6.3 pp |
| 2005 | 54.7% | €81.12 Million | €148.35 Million | €192.87 Million | €111.75 Million | — |